News

This June issue of Australian Prescriber explores both common and emerging challenges in clinical practice, emphasising integrated, patient‑centred care.

This April issue covers updates on the diagnosis and management of metabolic dysfunction-associated fatty liver disease (MAFLD), accurate measurement of blood pressure, vitamin B12 deficiency, and cytomegalovirus (CMV) infection in pregnancy.

This February issue features an editorial and an article about psychotropic medicines in people with cognitive disability or impairment.

The December issue marks a significant milestone as Professor Michael Kidd AO, Australia’s Chief Medical Officer, pens an editorial celebrating Australian Prescriber’s 50th anniversary.

The October issue of Australian Prescriber covers medications for ADHD in children and adolescents, how to select and use oral anticoagulants for AF and VTE, new Australasian consensus recommendations for screening and management of gestational diabetes and more.

The August issue features a practical guide on how to safely stop oral corticosteroids following short-term and longer-term use. It covers choosing an NSAID for pain, identifying potentially inappropriate medicines in older people, how to avoid pre-laboratory errors and more.

The June issue provides an update on long and shorter-acting contraceptive methods available in Australia. It covers pharmacogenomics to personalise drug therapy, the management of psoriasis in primary care, medicines for treating opioid dependence and more.

This year marks a momentous milestone in the history of Australian Prescriber, as we celebrate its 50-year anniversary.

The issue spotlights the timely topic of therapeutic use of vapes for smoking cessation and nicotine dependence and more.

The new issue addresses 2 challenges in clinical practice: medicine shortages and inhaler devices for people with asthma or chronic obstructive pulmonary disease (COPD) and more.

The issue highlights polycystic ovary syndrome, needlestick injuries and other blood or body fluid exposures in primary care, and more.

The new release of Australian Prescriber covers biologic treatments for severe asthma, obstructive sleep apnoea management, the 2023 Australian Guideline for Assessing and Managing Cardiovascular Disease Risk, and more.

The new release of Australian Prescriber covers the management of pre-existing diabetes prior to and during pregnancy, hypercholesterolaemia, eosinophilic oesophagitis, and the concept of therapeutic inertia. Also, a case study investigates a body builder’s severe liver injury after using the supplement RAD-140 (a SARM).